Rheumatologists should exercise caution in interpreting clinical trial results, with a particular awareness of potential ...
The FDA approved combination imlunestrant plus abemaciclib for adults with hormone therapy-resistant estrogen ...
Lawmakers questioned Nicole Saphier, MD, on abortion bans, vaccines and other preventive health issues during Wednesday’s ...
The inflection point has arrived.More than a dozen studies presented at ASCO Annual Meeting added to a growing volume of research that suggests GLP-1 receptor agonists may protect against several ...
The FDA has approved finerenone as a therapy to lower urinary albumin-to-creatinine ratio among adults with chronic kidney ...
On Sept. 23, Healio Community will host its first Mentorship Networking Event at 4 p.m. EDT, featuring an opportunity to connect with a mentor and gain career advice. The free webinar includes insight ...
In a new analysis of the SELECT trial published in JAMA Cardiology, semaglutide 2.4 mg improved clinical outcomes compared ...
In this video, Adam Friedman, MD, FAAD, emphasized the need for physicians to address misperceptions in atopic dermatitis and ...
The FDA accepted an investigational new drug application for the epinephrine intranasal powder OX640 for treating anaphylaxis ...
Data from a phase 3 study assessing more than 5,000 women and 500 pregnancies support the use of long-acting lenacapavir as HIV pre-exposure prophylaxis among pregnant, postpartum and lactating women, ...
On Thursday, HHS announced the appointments of eight new members to the U.S. Preventive Services Task Force, reshaping the ...
Atogepant, a calcitonin gene-related peptide receptor agonist, showed significant reductions in migraine days related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results